YASUSHI ICHIKAWA

Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet

MOTOKAZU SATO, Qinghong Han, Ryosuke Mori et al. · Anticancer Research · 2024 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan

Daisuke Sano, Motohiko Tokuhisa, Hideaki Takahashi et al. · Anticancer Research · 2022 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet

MOTOKAZU SATO, Qinghong Han, KOHEI MIZUTA et al. · In Vivo · 2024 · 21 citations · Full text

Medicine, Nuclear Medicine, Radiation Oncology +13

Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer

MOTOKAZU SATO, Qinghong Han, Yutaro Kubota et al. · Anticancer Research · 2023 · 17 citations · Full text

Medicine, Oncology, Pharmacology +15